FOUR new medicinal cannabis items can be ordered by community pharmacists effective from today, with the addition of Canndeo Limited hemp-based products to the PharmaPrograms' Medicinal Cannabis Medicines Portal (MCMP) (PD 12 Sep 2017).
The additions are being made available by ASX-listed The Hydroponics Company (THC), and include Endoca Hemp Oil - CBD and Endoca Raw Hemp Oil - CBD + CBDA in 3% and 15% concentrations.
The items are currently not scheduled on the Australian Register of Therapeutic Goods, and will be available under the Approved Prescriber Scheme (APS) and Special Access Scheme (SAS) Category B via the MCMP.
The Endoca products will be distributed in Australia by Anspec Pty Ltd, which will offer accounts to participating pharmacies.
If the relevant state health department does not issue pharmacy registration certificates, the owner pharmacist's AHPRA registration certificate and the pharmacy's Medicare agreement must be provided.
"In addition to facilitating supply, a structured pharmacy support program is an integral part of the MCMP," PharmaPrograms said, with the portal providing a streamlined process for medicinal cannabis prescribing and dispensing between health professionals and manufacturers of medicinal cannabis products.
Other companies using the MCMP portal include Cann and Medlab.
More info at mcmp.com.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Aug 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Aug 18
